⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

March 4, 2026

Is seltorexant, an orexin-2 receptor antagonist, showing promise in insomnia?

View Full Paper

Ask AI

Bookmark

Share

Key Points

To assess the efficacy and safety of seltorexant in treating insomnia.
Conducted a phase 2b trial focusing on insomnia
Measured latency to persistent sleep (LPS) on night 1
Compared seltorexant’s effects to zolpidem
Monitored treatment-emergent adverse effects
Seltorexant reduced latency to persistent sleep on the first night
Prolonged sleep time before waking was observed
Seltorexant showed more benefits and fewer adverse effects compared to zolpidem
Effects may diminish over time based on dosage
Lower incidence of treatment-emergent adverse effects than placebo

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Phase 2b trial evaluates seltorexant for insomnia, indicating its benefits over zolpidem.

Cite This Study

Sheila A Doggrell (2026) studied this question.

synapsesocial.com/papers/69a7cd8cd48f933b5eed9f3a https://doi.org/10.1080/13543784.2026.2637841

View Full Paper

Ask AI

Bookmark

Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Efficacy and Safety of Seltorexant in Insomnia Disorder: A Randomized Clinical Trial.2025 · 11 citations
2Evaluating seltorexant as a treatment option for major depressive disorderOriginal Research · 2026
3Safety, tolerability, and preliminary efficacy of seltorexant versus quetiapine extended release as adjunctive therapy in major depressive disorder: a randomized, flexible-dose, 6-month, parallel-group, exploratory studyHuman Clinical Trial · 2026 · 1 citations
4Orexin receptor antagonists for major depressive disorder: perspectives from a systematic review and meta-analysisMeta-Analysis · 2026 · 1 citations
5Orexinergic Receptor Antagonists as a New Therapeutic Target to Overcome Limitations of Current Pharmacological Treatment of Insomnia Disorder2024 · 22 citations